Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1623 of 5804
-
Custom video may ease brain tumor radiation anxiety
Symptom relief Recruiting nowThis trial studies whether a customized video intervention can help to reduce anxiety in brain cancer patients undergoing radiation treatment and their caregivers. A customized neuro-imaging referenced symptom video that describes symptoms and side effects specific to the patient…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Could a viagra drug help fight liver cancer? new trial tests unlikely combo
Disease control TerminatedBackground: A most common liver cancer in adults is hepatocellular carcinoma. Other kinds of liver cancer happen when colorectal or pancreatic cancer spreads to the liver. Researchers want to study if a combination of drugs helps people with these cancers. The drugs are nivoluma…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cream shows promise for rare skin condition
Disease control CompletedCutaneous microcystic lymphatic malformations (CMLMs) are rare conditions of children and adults resulting from abnormal embryologic development of lymphatic vessels. They present as clusters of vesicles full of lymph and blood of various extent. They ooze and bleed, inducing mac…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Hope for Hard-to-Treat Self-Injury: new behavioral approaches under study
Symptom relief OngoingAt least one quarter of the 18 million persons in the US with intellectual and developmental disabilities engage in self-injurious behavior (SIB), which can result in injuries, disfigurement, and loss of function (e.g., blindness). SIB that persists in the absence of social reinf…
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New fluid strategy aims to reduce organ failure in septic shock
Disease control CompletedMany observational studies have highlighted an independent association between fluid overload and clinical outcomes during septic shock. To optimize fluid balance, clinician has several options to consider carefully fluid administration and avoid fluid overload. More than a gener…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 26, 2026 18:50 UTC
-
Could an antibody tame inflammation in kidney patients?
Disease control CompletedPatients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial. The purpose of this trial is to determine a dose to select for a potential cardiovascular outcome trial with Ziltivekimab. Doses …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New daily pill could tame ulcerative colitis in japanese patients
Disease control CompletedJapanese patients with moderate or severe active ulcerative colitis as a subject when ozanimod 0.46 mg or 0.92 mg is orally administered is evaluated about dose response, efficacy and safety with placebo as a control.
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kidney cancer: targeted pill aims to stop tumor growth
Disease control Recruiting nowSingle arm, single site, open-label Phase II study of the effects of oral olaparib in participants with metastatic renal cell carcinoma that harbor an inactivating mutation in BAP-1, ATM, BRCA1, BRCA2, PALB2, CHEK2, BRIP1, RAD51C, BARD1, CDK12, CHEK1, FANCL, PP2R2A, RAD51B, RAD51…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Simple toilet training may ease Post-Stroke bladder problems
Symptom relief Recruiting nowThis observational study will address urinary disorders in subacute stroke patients. Patients without and with urinary disorders will be compared, and treatment outcome will be assessed among the latter.
Sponsor: University Rehabilitation Institute, Republic of Slovenia • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug candidate offers hope for Treatment-Resistant depression
Symptom relief CompletedThe study is a phase II, double-blind, randomized, placebo controlled, parallel, multicentric study in 110 patients with drug resistant depression.
Phase: PHASE2 • Sponsor: Mapreg • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Immunotherapy combo shows promise for advanced cervical cancer
Disease control TerminatedThis is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placebo (Treatment Arm 1 - monotherapy) or with AGEN1884 (Treatment Arm 2- combination therapy) for treatment of patients with advanced c…
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a shorter pill course beat chagas?
Disease control CompletedThe investigators are proposing to perform a double-blinded, non-inferiority randomized controlled trial comparing a short 30-day treatment with BZN 150mg/day (30d/150mg) vs. a 60-day treatment with BZN 300 mg/day (60d/300mg). The investigators will recruit not previously treated…
Phase: PHASE3 • Sponsor: Tulane University School of Public Health and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
One and done? Single-Dose radiation aims to simplify prostate cancer treatment
Disease control Recruiting nowThis prospective single-arm phase II study evaluates the safety, feasibility, quality-of-life effects, PSA kinetics, imaging response, and clinical outcomes of definitive ultra-high dose single-fraction external beam radiation therapy in patients with biopsy-proven NCCN intermedi…
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Mindfulness may keep psychosis at bay
Prevention CompletedPracticing mindfulness is popular and well-accepted for its benefits in improving mental and physical health. In particular, its benefits in promoting resilience to stress and well-being have been shown in studies involving different psychiatric conditions, as well as preventing …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
New epilepsy drug shows promise for kids in early trial
Disease control OngoingThe purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core study for seizure frequency in participants with pediatric epileptic syndrome (Cohort 1) and partial-onset seizures (POS) …
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
HIV drug trogarzo gets a speed boost: new shorter injections tested
Disease control CompletedThis study is designed to assess the safety and pharmacokinetic profile of 800 mg Trogarzo once every two weeks administered via "IV Push" or intramuscular injection. An initial "Sentinel Group" of 5 participants will begin receiving 800mg Trogarzo on a gradual schedule of increa…
Phase: PHASE3 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo shows promise in Hard-to-Treat breast cancer
Disease control OngoingThis study is exploring the safety/tolerabtility and preliminary efficacy of the combination of Ipatasertib with Aromatase inhibitor or Fulvestrant for patients with metastatic HR+ breast cancer.
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Rapid HIV test for newborns could save lives by getting treatment started faster
Diagnosis CompletedThe purpose of the study is to test the effect of the Alere™ q HIV-1/2 Detect (diagnostic assay) on uptake of HIV testing among HIV-exposed infants and young children, and health outcomes for HIV-infected infants and young children using a novel POC EID Community Model in Zambia.…
Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Simple blood test could catch cancer recurrence sooner
Knowledge-focused Recruiting nowEarlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to future translational research opportunities, including interventional trials in which…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Home workouts before surgery may boost recovery in frail seniors
Disease control CompletedAs a consequence of the increasing life expectancy hospitals are seeing a growing number of elderly patients undergoing elective surgery. These patients are likely to suffer from one or more chronic illnesses, malnutrition, reduced physical strength and mobility and sensory impai…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC